188 related articles for article (PubMed ID: 36358692)
1. Panel Sequencing of Primary Cutaneous B-Cell Lymphoma.
Wobser M; Schummer P; Appenzeller S; Kneitz H; Roth S; Goebeler M; Geissinger E; Rosenwald A; Maurus K
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358692
[TBL] [Abstract][Full Text] [Related]
2. Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma.
Maurus K; Appenzeller S; Roth S; Kuper J; Rost S; Meierjohann S; Arampatzi P; Goebeler M; Rosenwald A; Geissinger E; Wobser M
J Invest Dermatol; 2018 Jul; 138(7):1573-1581. PubMed ID: 29481902
[TBL] [Abstract][Full Text] [Related]
3. Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas.
Gallardo F; Pujol RM
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291756
[TBL] [Abstract][Full Text] [Related]
4. How I Diagnose Primary Cutaneous Marginal Zone Lymphoma.
Gibson SE; Swerdlow SH
Am J Clin Pathol; 2020 Sep; 154(4):428-449. PubMed ID: 32808967
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases.
Wobser M; Reinartz T; Roth S; Goebeler M; Rosenwald A; Geissinger E
Oncol Ther; 2016; 4(2):199-210. PubMed ID: 28261650
[TBL] [Abstract][Full Text] [Related]
6. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
Kempf W; Kazakov DV; Mitteldorf C
Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
[TBL] [Abstract][Full Text] [Related]
9. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
[TBL] [Abstract][Full Text] [Related]
11. Indurated Plaques on the Legs: Think Lymphoma.
Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
[TBL] [Abstract][Full Text] [Related]
14. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
15. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
Wilcox RA
Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
18. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.
Pinyol M; Cobo F; Bea S; Jares P; Nayach I; Fernandez PL; Montserrat E; Cardesa A; Campo E
Blood; 1998 Apr; 91(8):2977-84. PubMed ID: 9531609
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous follicular B-cell lymphoma: description of a series of 18 cases.
Franco R; Fernandez-Vazquez A; Rodriguez-Peralto JL; Bellas C; López-Ríos F; Sáez A; Villuendas R; Navarrete M; Fernandez I; Zarco C; Piris MA
Am J Surg Pathol; 2001 Jul; 25(7):875-83. PubMed ID: 11420458
[TBL] [Abstract][Full Text] [Related]
20. Genetic evolution of
Vogelsberg A; Steinhilber J; Mankel B; Federmann B; Schmidt J; Montes-Mojarro IA; Hüttl K; Rodriguez-Pinilla M; Baskaran P; Nahnsen S; Piris MA; Ott G; Quintanilla-Martinez L; Bonzheim I; Fend F
Haematologica; 2021 Oct; 106(10):2673-2681. PubMed ID: 32855278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
